Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Adx-102
2. Ald-102
3. Reproxalap
1. Reproxalap
2. Adx-102
3. 916056-79-6
4. Reproxalap [usan]
5. Ns-2
6. Ald-102
7. F0giz22ijh
8. Reproxalap (usan)
9. Ns2
10. Reproxalap [inn]
11. Unii-f0giz22ijh
12. Adx102
13. Chembl4297210
14. Schembl12228833
15. Gtpl10613
16. Ex-a3715
17. Sb18931
18. Example 5 [wo2018039197a1]
19. Hy-107150
20. Cs-0027443
21. D11309
22. 2-(3-amino-6-chloroquinolin-2-yl)-propan-2-ol
23. 2-quinolinemethanol, 3-amino-6-chloro-alpha,alpha-dimethyl-
24. 2-quinolinemethanol, 3-amino-6-chloro-.alpha.,.alpha.-dimethyl-
| Molecular Weight | 236.70 g/mol |
|---|---|
| Molecular Formula | C12H13ClN2O |
| XLogP3 | 2.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 236.0716407 g/mol |
| Monoisotopic Mass | 236.0716407 g/mol |
| Topological Polar Surface Area | 59.1 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 259 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Reproxalap inhibits Reactive Aldehyde Species (RASP) and is being investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjgren-Larsson syndrome.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Reproxalap manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Reproxalap, including repackagers and relabelers. The FDA regulates Reproxalap manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Reproxalap API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Reproxalap manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Reproxalap supplier is an individual or a company that provides Reproxalap active pharmaceutical ingredient (API) or Reproxalap finished formulations upon request. The Reproxalap suppliers may include Reproxalap API manufacturers, exporters, distributors and traders.
click here to find a list of Reproxalap suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Reproxalap Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Reproxalap GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Reproxalap GMP manufacturer or Reproxalap GMP API supplier for your needs.
A Reproxalap CoA (Certificate of Analysis) is a formal document that attests to Reproxalap's compliance with Reproxalap specifications and serves as a tool for batch-level quality control.
Reproxalap CoA mostly includes findings from lab analyses of a specific batch. For each Reproxalap CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Reproxalap may be tested according to a variety of international standards, such as European Pharmacopoeia (Reproxalap EP), Reproxalap JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Reproxalap USP).
LOOKING FOR A SUPPLIER?
